Clinical Trials
3
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
3 (100.0%)Biological Therapy in Previously Treated Patients With Non-small Cell Lung Cancer
Phase 2
- Conditions
- Lung Cancer
- First Posted Date
- 2004-08-02
- Last Posted Date
- 2013-11-06
- Lead Sponsor
- Cancer Biotherapy Research Group
- Target Recruit Count
- 30
- Registration Number
- NCT00003090
- Locations
- 🇺🇸
Bloomington Hospital, Bloomington, Indiana, United States
🇺🇸Bergan Mercy Medical Center, Omaha, Nebraska, United States
🇺🇸St. Joseph Regional Cancer Center, Bryan, Texas, United States
Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer That Has Been Removed With Surgery
Phase 2
- Conditions
- Kidney Cancer
- First Posted Date
- 2004-07-16
- Last Posted Date
- 2013-11-06
- Lead Sponsor
- Cancer Biotherapy Research Group
- Target Recruit Count
- 20
- Registration Number
- NCT00003604
- Locations
- 🇺🇸
Cancer Care Center for Southern Indiana, Bloomington, Indiana, United States
🇺🇸Bergan Mercy Medical Center, Omaha, Nebraska, United States
🇺🇸Baptist Regional Cancer Center - Knoxville, Knoxville, Tennessee, United States
Combination Chemotherapy and Biological Therapy In Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed Surgically
Phase 2
- Conditions
- Kidney Cancer
- First Posted Date
- 2004-07-16
- Last Posted Date
- 2013-11-06
- Lead Sponsor
- Cancer Biotherapy Research Group
- Target Recruit Count
- 30
- Registration Number
- NCT00003664
- Locations
- 🇺🇸
Bloomington Hospital, Bloomington, Indiana, United States
🇺🇸Bergan Mercy Medical Center, Omaha, Nebraska, United States
News
No news found